4410
HARIMA CHEMICALS GROUP,INC.
ハリマ化成グループ
- Industry
- Chemicals
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Mar 2021
62,851
Mar 2022
76,093
Mar 2023
94,511
Mar 2024
92,330
Mar 2025
101,006
Operating profit(million JPY)
Mar 2021
1,577
Mar 2022
3,251
Mar 2023
1,706
Mar 2024
-211
Mar 2025
2,083
Operating profit margin(%)
Mar 2021
2.51
Mar 2022
4.27
Mar 2023
1.81
Mar 2024
-0.23
Mar 2025
2.06
Profit before tax(million JPY)
Mar 2021
2,316
Mar 2022
2,995
Mar 2023
2,323
Mar 2024
-251
Mar 2025
1,818
Profit(million JPY)
Mar 2021
1,091
Mar 2022
1,746
Mar 2023
886
Mar 2024
-1,161
Mar 2025
763
Total assets(million JPY)
Mar 2021
69,390
Mar 2022
78,905
Mar 2023
92,439
Mar 2024
98,583
Mar 2025
100,044
Cash and cash equivalents(million JPY)
Mar 2021
3,422
Mar 2022
5,339
Mar 2023
6,219
Mar 2024
6,633
Mar 2025
4,645
Cash flows from operating activities(million JPY)
Mar 2021
3,008
Mar 2022
2,833
Mar 2023
-466
Mar 2024
353
Mar 2025
6,145
Cash flows from investing activities(million JPY)
Mar 2021
-1,858
Mar 2022
-3,439
Mar 2023
-6,649
Mar 2024
-3,197
Mar 2025
-4,980
Cash flows from financing activities(million JPY)
Mar 2021
-1,565
Mar 2022
2,107
Mar 2023
7,657
Mar 2024
2,895
Mar 2025
-3,669
Return on equity(%)
Mar 2021
3.13
Mar 2022
4.9
Mar 2023
2.4
Mar 2024
-3.13
Mar 2025
2
Equity ratio(%)
Mar 2021
49.81
Mar 2022
46.56
Mar 2023
40.14
Mar 2024
37.75
Mar 2025
37.3
Earnings per share(JPY per share)
Mar 2021
43.44
Mar 2022
69.42
Mar 2023
35.76
Mar 2024
-47.96
Mar 2025
31.46
Net assets per share(JPY per share)
Mar 2021
1,375.27
Mar 2022
1,459.97
Mar 2023
1,533.01
Mar 2024
1,535.78
Mar 2025
1,538.53
Dividend per share(JPY per share)
Mar 2021
38
Mar 2022
38
Mar 2023
42
Mar 2024
42
Mar 2025
42
Payout ratio(%)
Mar 2021
87.48
Mar 2022
54.74
Mar 2023
117.45
Mar 2024
-
Mar 2025
133.5
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.